Developments in the field of biotechnology have been categorized into three ‘waves’ or stages. In the first stage or the ‘green wave’, the industry was dominated by the agricultural applications of biotechnology. This was followed by medical applicat ....see more
The global aptamers market in terms of revenue was estimated to be worth $151 million in 2021 and is poised to reach $342 million by 2026, growing at a CAGR of 17.7% from 2021 to 2026. Growth of the market is attributed to factors such as increase in number of clinical trials for development of aptamer-based therapeutics, increase in awareness about advantages of aptamers as compared to antibodies, rising investment in pharmaceutical R&D, and rising prevalence of chronic and rare diseases to increase the demand for aptamer-based therapeutics and diagnostics. Growth in the venture capital funding for research on aptamers and growing collaborations with research institutes and pharmaceutical companies are also expected to offer a wide range of growth opportunities to players in the market.
The animal growth promoters and performance enhancers market industry is projected to grow from USD 16.2 billion in 2021 and to reach USD 21.4 billion by 2026, at a Compound Annual Growth Rate (CAGR) of 5.7% during the forecast period. Prominent players in the Animal Growth Promoters and Performance Enhancers Market include are Cargill, Incorporated (US), Royal DSM N.V. (Netherlands), Elanco Animal Health Incorporated (US), Boehringer Ingelheim Group (Germany), Merck & Co., Inc (US), Alltech Corporation (US), Archer-Daniels-Midland Company (ADM) (US), Vetoquinol S.A. (France), Bupo Animal Health Pty Ltd. (South Africa) and Novus International, Inc. (US).
The bioprocess containers market size is projected to reach USD 9.6 billion by 2026, at a CAGR of 26.3%. The major players operating in this market are Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher Corporation (US), and Merck Millipore (Germany)
The global protein characterization market in terms of revenue was estimated to be worth $12.6 billion in 2021 and is poised to reach $23.9 billion by 2026, growing at a CAGR of 13.7% from 2021 to 2026. Thermo Fisher Scientific (US), Danaher Corporation (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), and Waters Corporation (US) are the prominent players operating in the protein characterization and identification market.
The global Single Cell Analysis Market in terms of revenue was estimated to be worth $3.1 billion in 2021 and is poised to reach $6.3 billion by 2026, growing at a CAGR of 15.1% from 2021 to 2026. The prominent players in the single-cell analysis market are Becton, Dickinson and Company (US), Danaher Corporation (US), Merck KGAA (Germany), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (US), Promega Corporation (US), Illumina, Inc. (US), Fluidigm Corporation (US), 10X Genomics (US), and Corning Incorporated (US).
The global single use bioreactors market in terms of revenue was estimated to be worth $3.4 billion in 2021 and is poised to reach $8.8 billion by 2026, growing at a CAGR of 21.1% from 2021 to 2026. The prominent players operating in this market are Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher Corporation (US), and Merck KGaA (Germany).
The global single use bioprocessing market in terms of revenue was estimated to be worth $8.2 billion in 2021 and is poised to reach $20.8 billion by 2026, growing at a CAGR of 20.5% from 2021 to 2026. Growth of this market is driven by factors such as the increasing demand for biopharmaceuticals and energy efficiency, the need to reduce water wastage and equipment floor space requirements, and the risk of cross-contamination. However, extractability and leachability issues regarding disposable components and environmental and economic concerns are the major factors restraining market growth.
The global collagen and gelatin market in terms of revenue was estimated to be worth $772 million in 2021 and is poised to reach $1,083 million by 2026, growing at a CAGR of 7.0% from 2021 to 2026. Key players in this market includes Integra LifeSciences (US), Royal DSM (Netherlands), CollPlant Biotechnologies (Israel), Nitta Gelatin Inc. (Japan), Collagen Solutions plc (UK), Collagen Matrix, Inc. (US), Symatese (France), GELITA AG (Germany), PB Leiner (Belgium), Smith & Nephew (UK), Zimmer Biomet (US).
The global hollow fiber filtration market in terms of revenue was estimated to be worth $303 million in 2021 and is poised to reach $597 million by 2026, growing at a CAGR of 14.5% from 2021 to 2026. Prominent players in the hollow fiber filtration market are Repligen Corporation (US), Danaher (US), Asahi Kasei Corporation (Japan), Parker-Hannifin Corp (US), Sartorius Stedim Biotech S.A (France), TOYOBO CO., LTD (Japan), and Cantel Medical (US). The key players in this market are focusing on strategic expansions, and acquisition to expand their presence in the market.
The global animal genetics market in terms of revenue was estimated to be worth $5.5 billion in 2021 and is poised to reach $7.7 billion by 2026, growing at a CAGR of 7.1% from 2021 to 2026. The growth in this market is mainly driven by the rising consumption of animal-derived protein and the increasing global population and rapid urbanization. Additionally, a growing focus on identifying superior breeds, increased adoption of genetic services to prevent genetic diseases and business loss, and increased adoption of advanced genetic technologies also contribute to the growth of the market.
The global molecular biology enzymes market in terms of revenue was estimated to be worth $15.3 billion in 2021 and is poised to reach $29.7 billion by 2026, growing at a CAGR of 14.2% from 2021 to 2026. Some key players operating in this market are Thermo Fisher (US), Merck (Germany), Illumina (US), QIAGEN (Netherlands), New England Biolabs (US), Promega (US), Agilent (US), Roche (Switzerland), Takara Bio (Japan), Bio Basic (Canada), Jena Bioscience (Germany), Molecular Biology Resources (US), Bio-Rad Laboratories, Inc. (US).
The global Stem Cell Manufacturing Market boasts a total value of $11.5 billion in 2021 and is projected to register a growth rate of 9.4% to reach a value of $18.0 billion by 2026. Key players operating in this market are Thermo Fisher Scientific (US), Merck Milliopore (Germany), Lonza Group AG (Switzerland), Danaher Corporation (US) and Sartorius AG (Germany).
The PDX model market is expected to grow from USD 140 million in 2021 to USD 299 million by 2026, at a compound annual growth rate (CAGR) of 16.4% during the forecast period.JSR Corporation (Japan), WuXi AppTec (China), Champions Oncology, Inc. (US), The Jackson Laboratory (US), Oncodesign (France), Charles River Laboratories (US), Hera Biolabs (US), EPO Berlin-Buch (Germany), Envigo (US), Xentech (France), Urosphere (France), and Explora BioLabs (US).
The global oxidative stress assay market in terms of revenue was estimated to be worth $836 million in 2020 and is poised to reach $1,326 million by 2025, growing at a CAGR of 9.7% from 2020 to 2025. Major players operating in the market include Abcam, plc (UK), Enzo Biochem, Inc. (US), Merck KGaA (Germany), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (US), AMS Biotechnology (Europe), Ltd. (UK), BioVision, Inc. (US), Cell Biolabs, Inc. (US), Oxford Biomedical Research (US), Promega Corporation (US), Cayman Chemical (US), Eagle Biosciences, Inc. (US), Arbor Assays (US), Hycult Biotech (Netherlands), Callegari SRL (Italy), Kamiya Biomedical Company (US), MEGA TIP San.Tic.Ltd.Sti. (Turkey), ImmunoChemistry Technologies, LLC (US), Genox Corporation (US), and Toxys B.V. (Netherlands).
The global in in vivo toxicology market is expected to grow from USD 5.5% between 2020 to USD 6.6 billion by 2025, at a compound annual growth rate (CAGR) of 5.5% during the forecast period.Charles River Laboratories (US), The Jackson Laboratory (US), Envigo (US), Taconic Biosciences, Inc. (US), and JANVIER LABS (France), Thermo Fisher Scientific (US), Danaher Corporation (US), Waters Corporation (US), Agilent Technologies (US), Shimadzu Corporation (Japan), Bruker Corporation (US), PerkinElmer (US). Other prominent players include Merck KGaA (Germany), GE Healthcare (US), and Bio-Rad Laboratories (US), genOway (France), Cyagen Biosciences (US), GVK BIO (India), PolyGene (Switzerland), Crown Biosciences (US), TransCure bioServices (France), Ozgene Pty Ltd. (Australia), Harbour BioMed (US) among others.
The global microcarrier market in terms of revenue was estimated to be worth $1.7 billion in 2021 and is poised to reach $2.9 billion by 2026, growing at a CAGR of 10.7% from 2021 to 2026. Additional company profiles have been added (a total of 20 companies profiled). Additional points in the market overview have been added, keeping in mind the impact of COVID-19 on the overall microcarrier market.
The global cell-based assays market boasts a total value of $14.9 billion in 2020 and is projected to register a growth rate of 8.1% to reach a value of $22.0 billion by 2025. Prominent players in the market are Danaher Corporation (US), Thermo Fisher Scientific (US), Merck KGaA (Germany), Becton, Dickinson and Company (US).
The global cell lysis market in terms of revenue was estimated to be worth $2.9 billion in 2021 and is poised to reach $4.1 billion by 2026, growing at a CAGR of 7.2% from 2021 to 2026. The 2021 edition of the report provides market size and forecasts for each of the regions along with their countries. Pricing analysis, supply analysis, value chain analysis, ecosystem analysis of the cell lysis market, Porter's Five Forces analysis, trade analysis, patent analysis, technology analysis, and regulatory outlook have been added. Growth of the market is driven mainly by increasing government funding for research, the high prevalence of diseases, and a growing focus on personalised medicine.
The Proteomics Market is projected to reach USD 55.9 billion by 2026, at a CAGR of 16.6% during the forecast period. The major players operating in this market are Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Bruker Corporation (US), Danaher Corporation (US), GE Healthcare (US), Luminex Corporation (US), PerkinElmer Inc. (US), Waters Corporation (US), Illumina, Inc. (US), Eurofins Scientific (Luxembourg), QIAGEN Bioinformatics (Netherlands), Creative Proteomics (US), Promega Corporation (US), Sengenics (Singapore), Biomax Informatics AG (Germany), MS Bioworks LLC (US), WuXi NextCODE (China), Fios Genomics Ltd. (UK), GENEWIZ (US), Biognosys AG (Switzerland), Bioproximity (Switzerland), MRM Proteomics Inc. (Canada), Integrated Proteomics Applications (US), Poochon Scientific, LLC (US), Proteome Factory AG (Germany), VProteomics (India), HORIBA, Ltd. (Japan), and Applied Biomics, Inc. (US).
The global digital PCR market in terms of revenue was estimated to be worth $4.9 billion in 2020 and is poised to reach $7.6 billion by 2025, growing at a CAGR of 9.0% from 2020 to 2025. The shift from plant-derived to genome-based drug discovery is expected to offer significant opportunities for the expansion of the global dPCR and qPCR markets. The field of drug discovery has witnessed a major shift from an empirical approach rooted in plant-derived drug-based therapies to a target-oriented, genome-based therapeutic approach.
The global high throughput screening market in terms of revenue was estimated to be worth $15.3 billion in 2020 and is poised to reach $26.4 billion by 2025, growing at a CAGR of 11.5% from 2020 to 2025. Key players in the high-throughput screening market include Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Danaher Corporation (US), PerkinElmer, Inc. (US), Tecan Group Ltd. (Switzerland), AXXAM S.p.A. (Italy), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Promega Corporation (US), Corning Incorporated (US), and Eurofins Scientific (Luxembourg).
The global genomics market in terms of revenue was estimated to be valued at $18.9 billion in 2019 and is poised to reach $22.7 billion in 2020 and $54.4 billion by 2025, growing at a CAGR of 19.0%. In the last edition of the report, the base year was 2016 and the forecast period was 2017–2022. The updated study has 2019 as the base year, and the forecast period is 2020–2025. The new research study includes the impact of COVID-19 on the genomics market. The pandemic has had a positive impact on the market due to a large number of innovative product developments by market players for SARS-CoV-2 testing and the wide usage of genomic products in COVID-19 research.
The immunofluorescence assays market is expected to grow from USD 2.6 billion in 2021 to USD 83.5 billion by 2026, at a compound annual growth rate (CAGR) of 6.0% during the forecast period.Thermo Fisher Scientific Inc (US), Abcam PLC (UK), Bio-Rad Laboratories, Inc (US), PerkinElmer Inc. (US), Merck KGaA (Germany), Werfen Company (Spain), Cell Signaling Technology, Inc. (US), MEDIPAN GmbH (Germany)
The global cannabis testing market size is projected to reach USD 1,806 million by 2025, at a CAGR of 13.4% during the forecast period. The major players operating in this market are Agilent Technologies, Inc. (US), Shimadzu Corporation (Japan), MERCK KGAA (Germany), Thermo Fisher Scientific (US), DigiPath, Inc. (US), Steep Hill Inc. (US), SC Laboratories, Inc. (US), and PharmLabs LLC (US).
The Asia Pacific Single-cell Analysis Market is expected to grow from USD 550 million in 2020 to USD 1,375 million by 2025, at a CAGR of 20.1% during the forecast period. The major players operating in this market are Becton, Dickinson and Company (US), Danaher Corporation (US), Merck Millipore (US), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (US), General Electric Company (US), Promega Corporation (US), Illumina, Inc. (US), Bio-Rad Laboratories (US), Fluidigm Corporation (US), Agilent Technologies, Inc. (US), Tecan Group Ltd. (Switzerland), Sartorius AG (Germany), Luminex Corporation (US), Takara Bio (Japan), 10x Genomics (US), Fluxion Biosciences (US), Menarini Silicon Biosystems, Inc. (Italy), bioMérieux SA (France), Oxford Nanopore Technologies (UK), Cytek Biosciences (US), Corning Incorporated (US), Apogee Flow Systems Ltd. (UK), NanoCellect Biomedical (US), and On-chip Biotechnologies Co., Ltd. (Japan).
The global biomaterials market in terms of revenue was estimated to be worth $35.5 billion in 2020 and is poised to reach $47.5 billion by 2025, growing at a CAGR of 6.0% from 2020 to 2025. Market growth is driven mainly by factors such as the increased funds & grants by government bodies worldwide for the development of novel biomaterials, rising demand for medical implants, and the rising incidence of cardiovascular diseases, increasing research on regenerative medicine.
The global infrared spectroscopy market size is projected to reach USD 1.3 billion by 2025, growing at a CAGR of 5.2%. And, The global terahertz spectroscopy market is projected to reach USD 45 million by 2025, growing at a CAGR of 8.3%. Prominent players in this market are PerkinElmer (US), Bruker Corporation (US) Shimadzu Corporation (US), Thermo Fisher Scientiific (US), Agilent Technologies (US).
The global pharmaceutical membrane filtration market is projected to reach USD 10.2 billion by 2025, growing at a CAGR of 12.0% during the forecast period. The major companies operating in the pharmaceutical membrane filtration market include Merck (Germany), Danaher (US) and Sartorius Stedim Biotech (France).
The global metabolomics market market in terms of revenue was estimated to be worth $1.9 billion in 2020 and is poised to reach $4.1 billion by 2025, growing at a CAGR of 13.4% from 2020 to 2025. Some of the prominent players in the market are Waters Corporation (US), Agilent Technologies (US), Shimadzu Corporation (Japan), Thermo Fisher Scientific (US), Danaher Corporation (US), Bruker Corporation (US), PerkinElmer (US), Merck KGaA (Germany), GE Healthcare (US), Hitachi High-Technologies Corporation (Japan), Human Metabolome Technologies, Inc. (Japan), LECO Corporation (US), Metabolon, Inc. (US), Bio-Rad Laboratories (US), Scion Instruments (US), DANI Instruments S.p.A. (Italy), GL Sciences (Japan), SRI Instruments (US), Kore Technology Ltd. (UK), and JASCO, Inc. (US) among others.
The global cell isolation market in terms of revenue was estimated to be worth $6.9 billion in 2020 and is poised to reach $15.0 billion by 2025, growing at a CAGR of 16.8% from 2020 to 2025. The major players operating in this market are Thermo Fisher Scientific, Inc. (US), Becton, Dickinson and Company Limited (US), Beckman Coulter Inc. (US).Merck KGaA (Germany), Terumo BCT (Japan), GE Healthcare (US), Bio- Rad Laboratories Inc. (US), Corning Inc. (US), Roche Diagnostics (Switzerland, Alfa Laval (Sweden), Miltenyl Biotech (Germany), pluriSelect Life Science (Germany), STEMCELL Technologies Inc. (Canada), Akadeum Life Sciences, Inc (US), Bio- Techne (US), Bio Legend (US) and Invent Biotechnologies (US).
The global genetic toxicology testing market is projected to reach USD 2.0 billion by 2025, at a CAGR of 10.2%. Prominent players in this market are Thermo Fisher Scientific, Inc. (US), Charles River Laboratories International, Inc. (US), Laboratory Corp Of America Holdings (US), Eurofins Scientific (Germany), Jubilant Life Sciences Limited (India), Merck KGaA (Germany), Toxikon Corporation (US), and Gentronix Limited (UK).
The human organoids market size is projected to reach USD 1,901 million by 2025, at a CAGR of 17.5%. Prominent players in this market BioIVT (US), Thermo Fisher Scientific (US), ZenBio (US), Corning (US), Organovo (US), Cyprio (France), Biopredic International (France), CELLINK (Sweden), Emulate (US), Hµrel Corporation (US), InSphero (Switzerland), Kerafast (US), Kirkstall (UK), and MIMETAS (Netherlands).
The global chiral chromatography column market size is projected to reach USD 123 million by 2025, at a CAGR of 4.5%. The major players in this market are Agilent Technologies (US), Thermo Fisher Scientific(US), Waters Corporation(US), Daicel Corporation (Japan), Bio-Rad Laboratories(US), W.R.Grace & Co. (US), Merk Group(Germany), GL Sciencies(Japan), Perkin Elmer (US), Shimadzu Corporation (Japan), Sartorious Group (Germany), Cytiva(US), ES Industruies (US), and Phenomenex (US).
The global mycoplasma testing market in terms of revenue was estimated to be worth $689 million in 2020 and is poised to reach $1,095 million by 2025, growing at a CAGR of 9.7% from 2020 to 2025. The major players operating in this market are Thermo Fisher Scientific, Inc. (US), Charles River Laboratories International, Inc. (US), Lonza Group Ltd. (Switzerland), Merck KGaA (Germany), Roche Diagnostics (Switzerland), American Type Culture Collection (US), Bionique Testing Laboratories, Inc. (US), InvivoGen (US), PromoCell GmbH (Germany), Biological Industries Israel Beit Haemek Ltd. (Israel), Creative Bioarray (US), Mycoplasma Experience (UK), Norgen Biotek Corp. (Canada), Agilent Technologies (US), Biotools B & M Labs, S.A. (Spain), Eurofins Scientific (Luxembourg), GeneCopoeia, Inc. (US), GenBio (Canada), Minerva Biolabs GmbH (Germany), Meridian Bioscience, Inc. (US), Sartorius AG (Germany), Savyon Diagnostics (Israel), Nelson Laboratories Fairfield, Inc. (US), Clongen Laboratories, LLC (US), and ScienCell Research Laboratories, Inc. (Canada).
The global analytical standards market in terms of revenue was estimated to be worth $1.3 billion in 2020 and is poised to reach $1.7 billion by 2025, growing at a CAGR of 6.3% from 2020 to 2025. Prominent players in this market include Merck KGaA (Germany), Agilent Technologies (US), Waters Corporation (US), LGC Standards (UK), PerkinElmer, Inc. (US), Restek Corporation (US), SPEX CertiPrep (US), AccuStandard, Inc. (US), Thermo Fisher Scientific, Inc. (US), and Mallinckrodt (UK).
The global pyrogen testing market in terms of revenue was estimated to be worth $927 million in 2020 and is poised to reach $1,689 million by 2025, growing at a CAGR of 12.7% from 2020 to 2025. The major players operating in this market are Charles River Laboratories, Inc. (US), Lonza (Switzerland), Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (US), Associates of Cape Cod, Inc. (US), GenScript Biotech Corporation (China), bioMérieux SA (France), FUJIFILM Wako Pure Chemical Corporation (Japan), Eurofins Scientific (Luxembourg), WuXi AppTec (China), Hycult Biotech (Netherlands), Ellab A/S (Denmark), Microcoat Biotechnologie GmbH (Germany), InvivoGen (US), Nelson Laboratories, LLC (US), Almac Group (UK), Pacific Biolabs (US), STERIS plc (US), Accugen Laboratories, Inc. (US), TOXIKON (US), Minerva Analytix GmbH (Germany), Indoor Biotechnologies, Inc. (US), Creative Bioarray (US), Lucideon Limited (UK), and North American Science Associates, Inc. (US).
The global RNA analysis market is projected to reach USD 8.7 billion by 2025, at a CAGR of 13.9%. The prominent players in this market are Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Illumina, Inc. (US), QIAGEN N.V. (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US).
The global live cell imaging market in terms of revenue was estimated to be worth $1.8 billion in 2020 and is poised to reach $2.8 billion by 2025, growing at a CAGR of 8.8% from 2020 to 2025. The prominent players in this market are Danaher Corporation (US), Carl Zeiss AG (Germany), Nikon Corporation (Japan), Olympus Corporation (Japan), PerkinElmer, Inc. (US), GE Healthcare (US), Bruker Corporation (US), Thermo Fisher Scientific Inc. (US), Sartorius AG (Germany), Oxford Instruments (UK), BioTek Instruments (US), Etaluma, Inc. (US), CytoSMART Technologies (Netherlands), NanoEnTek Inc. (Korea), Phase Focus Limited (UK), Tomocube, Inc. (South Korea), Phase Holographic Imaging PHI AB (Sweden), BD Biosciences (US), Sony Biotechnology, Inc. (US), Merck KGaA (Germany), KEYENCE Corporation (Japan), ibidi GmbH (Germany), Bio-Rad Laboratories (US), Logos Biosystems (South Korea), and Nanolive SA (Switzerland).
The global microbial identification market in terms of revenue was estimated to be worth $3.2 billion in 2020 and is poised to reach $5.7 billion by 2025, growing at a CAGR of 12.2% from 2020 to 2025. Some of the leading players in the microbial identification market include bioMérieux SA (France), Becton, Dickinson and Company (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Bruker Corporation (US), Shimadzu Corporation (Japan), QIAGEN NV (Netherlands), Avantor, Inc. (US), and Biolog, Inc. (US)
The global cartilage repair market in terms of revenue was estimated to be worth $787 million in 2020 and is poised to reach $1,603 million by 2025, growing at a CAGR of 15.3% from 2020 to 2025. Prominent players in the cartilage repair and regeneration market are Smith & Nephew plc (UK), DePuy Synthes (US), Zimmer Biomet (US), CONMED Corporation (US), Stryker Corporation (US), and Vericel Corporation (US).
The Primary Cells Market is projected to reach USD 1,613 million by 2025, at a CAGR of 10.7%. The major players operating in this market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Lonza (Switzerland), Cell Biologics, Inc. (US), PromoCell GmbH (Germany), HemaCare Corporation (US), ZenBio, Inc. (US), STEMCELL Technologies, Inc. (Canada), Corning Incorporated (US), AllCells (US), American Type Culture Collection (US), Axol Bioscience Ltd. (UK), iXCells Biotechnologies (US), Neuromics (US), StemExpress (US), BioIVT (US), ScienCell Research Laboratories, Inc. (US), PPA Research Group, Inc. (US), Creative Bioarray (US), BPS Bioscience, Inc. (US), Epithelix Sàrl (Switzerland), ReachBio LLC (US), AcceGen (US), Sekisui XenoTech, LLC (US), and Biopredic International (France).
The global mice model market in terms of revenue was estimated to be worth $1.4 billion in 2020 and is poised to reach $1.9 billion by 2025, growing at a CAGR of 6.4% from 2020 to 2025. The major players operating in this market Charles River Laboratories, (US) The Jackson Laboratory (US), Taconic Biosciences, Inc. (US), Envigo (US), JANVIER LABS (France), genOway (France), PolyGene (Switzerland), Crown Biosciences (US), TransCure Bioservices (France), Ingenious Targeting Laboratory (US), Cyagen Biosciences (US), GVK BIO (India), The Andersons, Inc. (US), Innovive (US), Allentown, LLC (US), FENGSHI GROUP (China), Ozgene Pty Ltd. (Australia), Harbour Biomed (US) among others.
The global label-free detection market size is projected to reach USD 626 million by 2025, at a CAGR of 7.7% during the forecasting period. Some of the leading players in the label-free detection market include Danaher (US), Sartorius AG (Germany), Waters Corporation (US), PerkinElmer Inc. (US), AMETEK, Inc. (US), HORIBA Ltd. (Japan), Spectris (UK), METTLER TOLEDO (US), Corning Incorporated (US), and Agilent Technologies, Inc. (US)
The global cell expansion market in terms of revenue was estimated to be worth $14.9 billion in 2020 and is poised to reach $30.1 billion by 2025, growing at a CAGR of 15.1% from 2020 to 2025. Some of the leading players in the cell expansion market include Thermo Fisher Scientific, Inc. (US), Danaher (US), Becton, Dickinson and Company (US), Lonza (Switzerland), Corning, Inc. (US), Merck KGaA (Germany), Sartorius Stedim Biotech (France), Getinge AB (Sweden) Terumo Corporation (Japan), and Miltenyi Biotec (Germany)
The global aseptic sampling market is projected to reach USD 474 million by 2025 from USD 264 million in 2020, at a CAGR of 12.4%. Market growth is driven mainly by the increasing demand for biopharmaceuticals, stringent government regulations to ensure drug safety, and funding to support life sciences research activities.
The global biopreservation market is projected to reach USD 4.9 billion by 2025, at a CAGR of 9.1%. The prominent players in this market includes Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), and Avantor, Inc. (US) ThermoGenesis Holdings, Inc. (US), Bio-Techne Corporation (US), BioLife Solutions, Inc. (US), Exact Sciences Corporation (US), (US), Worthington Industries, Inc. (US), and Chart Industries, Inc. (US).
The global cell counting market in terms of revenue was estimated to be worth $10.4 billion in 2020 and is poised to reach $14.5 billion by 2025, growing at a CAGR of 6.7% from 2020 to 2025. The major companies in the global market are Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Becton, Dickinson and Company (US), Merck KGaA (Germany), and Bio-Rad Laboratories (US).
The global protein crystallization market is projected to reach USD 1.7 billion by 2025, at a CAGR of 8.9%. The major companies in this market are Rigaku Corporation (Japan), Hampton Research (US), Jena Bioscience GmbH (Germany), and Bruker Corporation (US).
The Membrane Chromatography Market is projected to reach USD 408 million by 2025, at a CAGR of 15.5%. The major companies in the global membrane chromatography market are Sartorius AG (Germany), Danaher Corporation (US), Merck Millipore (Germany), Thermo Fisher Scientific (US), and 3M Company (US).
The depth filtration market is projected to reach USD 2.9 billion by 2025, at a CAGR of 9.0% during the forecast period. The major companies operating in the global depth filtration market include Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), GE Healthcare (US), 3M (US), Parker Hannifin Corporation (US), Porvair Filtration Group (UK), ErtelAlsop (US), Amazon Filters Ltd. (UK), Meissner Filtration Products, Inc. (US), Donaldson Comany, Inc. (US), Eaton Corporation (Ireland), Saint-Gobain Performance Plastics (France), Clariance Technique (Australia), Repligen Corporation (US), Microfilt India Pvt. Ltd. (India), Graver Technologies (US), Gusmer Enterprises (US), Filtrox AG (Switzerland), Pure Process (UK), Membrane Solutions (US), Allied Filter Systems Ltd. (UK), Pentair (US), Membracon (UK), and Phenomenex (US)